EKE. N. Kazinina

E. N. Kazinina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


E. N. Kazinina has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study of the relationship of LDH/AST ratio with the probability of manifestation and duration of HELLP syndrome (multicenter longitudinal analytical clinical trial)

    by N. Yu. Pylaeva, D. N. Protsenko, Y. M. Shifman, O. V. Ignatenko, A. V. Kulikov, Yu. S. Raspopin, O. V. Ryazanova, N. V. Lishchenko, A. V. Pylaev, E. V. Sadovaya, et al.

    Introduction. HELLP syndrome is a life-threatening complication of preeclampsia with high rates of maternal and perinatal morbidity, which necessitates the development of reliable prognostic markers of its manifestation and duration. The article presents the results of a multicenter retrospective analytical clinical trial «HELLP-RU», dedicated to assessing the prognostic significance of the ratio of lactate dehydrogenase to aspartate aminotransferase (LDH/AST) in pregnant women with preeclampsia.The objective was to evaluate the association between the lactate dehydrogenase to aspartate aminotransferase ratio (LDH/AST) and both the likelihood of HELLP syndrome manifestation and the duration of its clinical course. Materials and methods . This study included 139 female patientы diagnosed with complete or partial HELLP syndrome (2018–2022, 16 clinical centers). Laboratory and clinical data were analyzed at three predefined time points: upon hospital admission, immediately prior to delivery, and during the postpartum period. Temporal changes in the LDH/AST ratio were examined in relation to timing of disease onset and overall disease duration. Results . The distribution of complete and partial forms of HELLP syndrome varied across the stages of clinical observation. Dynamic analysis of the LDH/AST ratio demonstrated statistically significant intergroup differences. Persistently low LDH/AST ratios (< 5) were associated with a prolonged clinical course of HELLP syndrome, whereas higher ratios (> 10) correlated with its short-term course. Notably, a decline in the LDH/AST ratio in the absence of overt clinical deterioration preceded clinical manifestation of HELLP syndrome. Conclusions . The study revealed that the LDH/AST ratio is an accessible prognostic marker of the manifestation and duration of HELLP syndrome, which is important for timely clinical management and reducing the incidence of adverse outcomes.

  • Open Access

    Possibilities of Predicting the Manifestation of HELLP Syndrome

    by E. M. Shifman, N. Yu. Pylaeva, V. V. Gulyaev, A. V. Kulikov, A. V. Pylaev, E. N. Kazinina, E. N. Prochan

    Introduction. Despite the use of modern principles of treatment of severe preeclampsia, mortality rates for mother and newborn in the development of life-threatening complication of preeclampsia, such as HELLP syndrome, remains high. The introduction of accurate models of early diagnosis and prediction of the probability of manifestation and severity of the HELLP syndrome into everyday medical practice will improve the safety of delivery of pregnant women with severe preeclampsia.The aim of the study is to determine the current state of the issue and systematize current data on methods of predicting the probability of HELLP syndrome manifestation.Materials and methods. An analytical review of the literature. A qualitative analysis of clinical trials and reviews on prediction of HELLP syndrome was conducted using the following data sources: PubMed and Google Scholar. The search was carried out in Russian and English, using the keywords “predictors”, or “prediction”, and “HELLP syndrome”. The date of the last search query is 22 March 2024.Results. Anamnestic data and initial characteristics of patients with HELLP syndrome were analyzed.Discussion. The analytical review included publications devoted to the study of the influence of predictive capabilities of potential biochemical markers, clinical and anamnestic signs and instrumental examination data on the probability of HELLP syndrome development.Conclusion. Adequate prediction of the manifestation of HELLP syndrome is possible on the basis of a comprehensive analysis of all identified factors, allowing the identification of effective prognostic models to improve maternal and fetal outcomes in pregnant women with severe preeclampsia.